<prompt> Answer this question truthfullyWhat chronic myeloproliferative disorders are treated with Ruxolitinib and what specific mutations are associated with these disorders?  <response>: <reason> Ruxolitinib is used to treat chronic myeloproliferative disorders that have JAK2 mutations, which include myelofibrosis and polycythemia vera. 